EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Epidemiology and Clinical Impact of Confirmed Respiratory Viral Infections in Solid Organ Transplant Recipients

Manon L M Prins, Ernst D van Dokkum, Aiko P J de Vries, Maarten E Tushuizen, Danny van der Helm, Edwin M Spithoven, Irene M van der Meer, Eduard M Scholten, Albert M Vollaard, Saskia le Cessie, Leo G Visser, Geert H Groeneveld

Transplant Infectious Disease · 2026

DOI: 10.1111/tid.70128 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Manon L M Prins und 11 weiteren Autor:innen. Beteiligte Einrichtung: LUCID-Subdepartment of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Respiratory Tract Infections, Transplant Recipients, Organ Transplantation, Virus Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Respiratory viral infections (RVIs) can have distinct clinical presentations and outcomes in non‐lung solid organ transplant (SOT) recipients compared to non‐transplant and lung transplant patients. Understanding their impact is crucial for improving patient care and outcomes.

Methods

This multicenter retrospective study analyzed adult non‐lung SOT recipients with PCR‐confirmed symptomatic RVIs from eight Dutch hospitals (January 2013–July 2024) to characterize clinical characteristics and outcomes of mono‐ and co‐infections and identify risk factors for intensive care admission or 30‐day mortality.

Results

In total, 603 RVIs were identified in 460 recipients (kidney: 501; liver: 75; pancreas/islet of Langerhans: 4; combined: 23). The most common viruses were SARS‐CoV‐2 (36%), influenza A/B (29%), rhinovirus (14%), and RSV (7%). Influenza cases showed higher rates of fever (72%), common cold symptoms (37%), and myalgia (29%) than other viruses. Hospitalization occurred in 68% (384/565). Factors independently associated with intensive care admission or 30‐day mortality included higher CURB‐65 score (OR 1.91; 95% CI 1.36–2.70; p < 0.01), radiologic infiltrates (OR 3.04; 95% CI 1.60–5.80; p < 0.01), and SARS‐CoV‐2 infection (OR 1.67; 95% CI 1.05–2.67; p = 0.03). In contrast, influenza infection was associated with a lower risk (OR 0.21; 95% CI 0.07–0.62; p < 0.01). Co‐infections were not linked to worse outcomes compared to mono‐infections.

Conclusion

Overall, RVIs in non‐lung SOT recipients were associated with high hospitalization and mortality rates. SARS‐CoV‐2 posed the highest risk for complications, while influenza was associated with a lower risk of severe outcomes. No association was found between co‐infection and poor outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Tract InfectionsTransplant RecipientsOrgan TransplantationVirus DiseasesHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultRisk FactorsHospitalizationCoinfectionCOVID-19SARS-CoV-2NetherlandsInfluenza, Human

Stichwörter der Autor:innen

co‐infectionshospital admissionmono‐infectionsmorbidityrespiratory viral infectionssolid organ transplant recipients

Autor:innen und Institutionen

  • LUCID-Subdepartment of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Internal Medicine, Division Acute Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands.
  • Health Campus Leiden University Medical Center, The Hague, the Netherlands.
  • Department of Internal Medicine, Division of Nephrology and Leiden Transplant Center, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Zitieren

APA

Prins, M. L. M., van Dokkum, E. D., de Vries, A. P. J., Tushuizen, M. E., van der Helm, D., Spithoven, E. M., van der Meer, I. M., Scholten, E. M., Vollaard, A. M., le Cessie, S., Visser, L. G., & Groeneveld, G. H. (2026). Epidemiology and Clinical Impact of Confirmed Respiratory Viral Infections in Solid Organ Transplant Recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.70128

Vancouver

Prins MLM, van Dokkum ED, de Vries APJ, Tushuizen ME, van der Helm D, Spithoven EM, et al. Epidemiology and Clinical Impact of Confirmed Respiratory Viral Infections in Solid Organ Transplant Recipients. Transplant Infectious Disease. 2026. doi:10.1111/tid.70128

BibTeX
@article{Prins2026,
  author = {Prins, Manon L M and van Dokkum, Ernst D and de Vries, Aiko P J and Tushuizen, Maarten E and van der Helm, Danny and Spithoven, Edwin M and van der Meer, Irene M and Scholten, Eduard M and Vollaard, Albert M and le Cessie, Saskia and Visser, Leo G and Groeneveld, Geert H},
  title = {Epidemiology and Clinical Impact of Confirmed Respiratory Viral Infections in Solid Organ Transplant Recipients},
  journal = {Transplant Infectious Disease},
  year = {2026},
  doi = {10.1111/tid.70128}
}
Kostenlos starten →